We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

How Are We Developing Vaccines for the Future?

Article   May 30, 2018 | by Inez Cornell, Marketing Manager, Radleys

 
How Are We Developing Vaccines for the Future?
 
 
 

RELATED ARTICLES

Anti-inflammatory Drugs Resurrected To Fight Chronic Pain

Article

Failed drugs often are left on the shelf to gather dust. But sometimes, drugs can be dusted down and repurposed. That’s exactly the route that Katexco Pharmaceuticals has taken with its new immune system-targeting compounds, part of a new life sciences company that aims to target everything from multiple sclerosis to chronic pain.

READ MORE

Lipidomics – A Niche but Rapidly Growing Field

Article

Although researchers have been working on lipid biochemistry for many decades, lipidomics is a more recent, newly emerging discipline – with potential applications for diagnosing and preventing disease.

READ MORE

Novel Biomarker Can Accurately Detect Antibody-mediated Kidney Rejection

Article

An 8-gene assay which can non-invasively identify patients suffering from antibody-mediated rejection of kidney transplant has recently been discovered in a research study led by scientists at KU Leuven.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE